Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
OxytocinPregnancy
Interventions
DRUG

Oxytocin

"Induction-Vaginal Delivery: Begin at 1mU/min IV infusion and increase by 2mU/30min q30min to a max of 30mU/min. Postpartum infusion adjusted to 2U/hr.~Cesarian Delivery: 1U bolus via IV at delivery, followed by 7.5U/hr up to 30U/hour max depending on uterine tone. Postpartum infusion adjusted to 2U/hr"

Trial Locations (1)

94305

Lucile Packard Children's Hospital, Palo Alto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Giner, Inc

OTHER

collaborator

Aptagen, LLC

UNKNOWN

collaborator

Fraunhofer Center for Manufacturing Innovation

UNKNOWN

collaborator

Rose Biotech, LLC

UNKNOWN

lead

Stanford University

OTHER